Related by context. All words. (Click for frequent words.) 66 mm3 60 microlitre 59 microlitres 59 ug ml 59 μg mL 59 ug mL 59 nanoliters 58 ml min 58 ejection fraction EF 58 uL 57 microliters 57 microliter 57 micromolar 57 intravenous bolus injection 57 cellularity 57 lactate dehydrogenase 57 cm2 57 Gy fractions 57 μmol L 57 mL kg 57 nmol 56 microwatts 56 uM 56 precancerous adenomas 56 mm ³ 56 hepatic enzymes 56 SUVmax 56 QTcF 56 μg ml 56 4mg/kg 56 micromoles 56 oral allopurinol 56 mm2 56 milliliters mL 55 aspartate aminotransferase 55 mcg ml 55 #.#mL 55 pmol L 55 mCi 55 hours postdose 55 mcL 55 KRAS mutations occur 55 MBq 55 pleural fluid 55 ug g 55 IU ml 55 pmol liter 55 neutrophil counts 54 tectum 54 lopinavir r arm 54 nanoliter 54 mL/min/#.# m2 54 #mmHg [001] 54 leukocyte count 54 serum aminotransferase levels 54 octreotide LAR 54 mL sec 54 ug l 54 cells μL 54 μW 54 kD 54 mmHg diastolic 54 ejection fractions 54 virologic breakthrough 54 kGy 54 mmol kg 54 picogram 54 normal ULN 54 Gliadel Wafer 54 EDSS score 54 FDG uptake 54 #Gy 54 fraction LVEF 54 corticosteroid dose 53 W/cm2 53 nM 53 glomerular filtration 53 timepoints 53 μg L 53 deep venous thromboses 53 colorectal polyp 53 lung adenocarcinomas 53 thoracoabdominal 53 normothermic 53 micro sieverts 53 atheroma volume 53 MIC# [001] 53 mg TID 53 plasma HCV RNA 53 creatine kinase MB 53 nephrons 53 ruminal 53 mg kg hr 53 underwent surgical resection 53 fractional shortening 53 femoral condyles 53 ductal 53 p = #.# [003] 53 kilobases 53 serum IgG 53 cubic millimeter 53 pfu 53 pmol 53 μg g 53 Tumors shrank 53 Hazard Ratio HR 53 microwatt 53 mg/# g 53 mcg mL 53 nanowatts 53 ischemic lesions 53 g mL 53 T2 lesion volume 53 pT3 53 creatinine ratio 53 ropivacaine 53 macroalbuminuria 53 mL/min/#.# m 2 53 cm H2O 53 mIU ml 53 nondiabetic patients 53 echogenicity 53 nanomolar 53 occluded catheters 53 hepatorenal syndrome 52 micron thick 52 mediated dilation 52 PaO 2 52 segment binary restenosis 52 PASI scores 52 aspartate aminotransferase AST 52 interquartile range 52 mcg doses 52 advanced adenoma 52 Creatinine 52 mol L 52 μL 52 μl 52 mm ² 52 LAB GHRH 52 primary patency 52 log# reduction 52 scfm 52 glycated 52 urine albumin 52 mcg BID 52 mmol 52 alanine aminotransferase ALT 52 kVp 52 renal pelvis 52 mEq L 52 maximal plasma 52 mu m 52 bacteriuria 52 SCIg 52 μSv 52 mcg kg min 52 millivolts 52 polypoid 52 #mg/day [001] 52 Fig. 3b 52 Platelet counts 52 trabecular 52 injected subcutaneously 52 LV ejection fraction 52 infarct size 52 stent binary restenosis 52 5 HT2C receptor 52 sievert 52 daily subcutaneous injections 52 min -1 52 kBq kg 52 PREZISTA r arm 52 μg d 52 colorectal tumor 52 binary restenosis 52 cGy 52 microbiological eradication 51 subcapsular 51 colorectal adenoma 51 cm proximal 51 kg -1 51 achieved ACR# 51 mIU mL 51 Fig. 1D 51 millimoles 51 pg g 51 Fasting blood glucose 51 vitreous haze 51 Fasting glucose levels 51 detemir 51 T2 lesions 51 microvolts 51 ertapenem 51 Postoperatively 51 tissue oxygenation 51 #mg/kg [002] 51 mu g 51 cefazolin 51 advanced adenomas 51 myocytes 51 serum sodium levels 51 response CCyR 51 Serum creatinine 51 PSA nadir 51 Bulk density 51 CI -#.# 51 #.#dB [003] 51 microvessel density 51 parasitaemia 51 #.#ml [002] 51 lumbar spine bone 51 timepoint 51 #μg [001] 51 μg kg 51 macrophage infiltration 51 oxidised LDL 51 μM 51 T2 weighted MRI 51 pg mL 51 nmol l 51 achieved mucosal healing 51 IFN α 51 NNT = 51 oocyst 51 atazanavir ritonavir 51 mg QD 51 8mg/kg 51 Left ventricular ejection 51 μg doses 51 DAS# CRP 51 HbA1C levels 51 Breslow thickness 51 mmol l 51 mEq 51 ileum 51 1ppm 51 poloxamer 51 colorectal neoplasms 51 F FDG 51 deciliter 51 % CI #.#-#.# [003] 51 plasmacytoid 51 m 51 viral titers 51 -#.# log# copies mL 51 homogenates 51 contractile muscle 51 intraperitoneal injection 51 nanometers nanometer 51 μg l 51 interstitial fluid 51 X ULN 51 p = .# [001] 50 proximal tibial 50 SGPT 50 abdominal subcutaneous fat 50 Index CDAI score 50 ketorolac 50 W mK 50 Hazard Ratio = 50 μg dose 50 alanine transaminase 50 glycated hemoglobin levels 50 CDAI score 50 eluted 50 kilobase 50 microg 50 ± #.#mm [001] 50 specific antigen PSA 50 sieverts 50 absorption coefficient 50 zoledronate 50 pyridoxal 50 comparator arm 50 mmHg systolic 50 mg kg dose 50 iliac crest bone 50 ohm cm 50 supernatant 50 intravenous bolus 50 ETDRS 50 mmol liter 50 angstroms 50 tracer uptake 50 micromol 50 HBV DNA levels 50 lumbosacral spine 50 mcg QD 50 PBMCs 50 iobenguane 50 CD# + [001] 50 carotid artery thickness 50 maximal dose 50 low dose Iluvien 50 colonic mucosa 50 #.#mg/dL 50 milligram mg 50 invasive lobular 50 intracavitary 50 nadroparin 50 g cm 50 Figure 1A 50 #.#μm [001] 50 IFN alfa 50 #.#mg/kg [002] 50 aggrecan 50 mU liter 50 cm3 50 IRLS score 50 hip BMD 50 receiving VICTRELIS 50 % CI #.#-#.# [007] 50 diameter stenosis 50 gadolinium enhancing 50 #mg dose [002] 50 nontreated 50 ALT elevation 50 aneurysm sac 50 monophasic 50 micron pixels 50 postop 50 eosinophil count 50 nadolol 50 LDL particle 50 highest tertile 50 milliamperes 50 anagrelide 50 clodronate 50 cisplatin vinorelbine 50 serum phosphate levels 50 kilohertz kHz 50 p ≤ 50 peak plasma concentrations 50 millisieverts mSv 50 MWCNTs 50 gastric pH 50 micrometre 50 serum HCV RNA 50 parotid 50 MeV 50 saline placebo 50 phosphorus atom 50 mM 50 CIN3 + 50 FXIII 50 kg/m3 50 transaminase levels 50 pamidronate 50 micrograms mL 50 subcutaneously injected 50 serum concentrations 50 osteitis 50 microsomes 50 distal colon 50 arterial oxygen saturation 49 nanomolar range 49 millimeters mm 49 stenotic 49 kDa 49 ml kg 49 rFSH 49 IOP lowering 49 mcg albinterferon alfa 2b 49 complete cytogenetic response 49 hypervolemic 49 statistical significance p 49 endometrial thickness 49 oligohydramnios 49 sq. mm 49 ppbv 49 Fig. 1E 49 ventricular ejection fraction 49 salmeterol fluticasone propionate 49 cfu ml 49 serum sodium concentration 49 Kbits 49 .3 microns 49 hypophosphatemia 49 NIHSS 49 receiving Vectibix monotherapy 49 ug kg 49 μS cm 49 subcutaneous infusion 49 N telopeptide 49 #.#mm# [002] 49 MCF7 cells 49 hollow fibers 49 delivered subcutaneously 49 polymorphonuclear leukocytes 49 posttreatment 49 x ULN 49 vasopressor 49 severe neutropenia 49 -#.# mg dL [002] 49 pg ml 49 weekly CSBMs 49 microemboli 49 x #.#cm [001] 49 biopsy Gleason 49 evaluable subjects 49 SGOT 49 Gigaflops 49 acetaminophen codeine 49 HER2 expression 49 EUFLEXXA R 49 5μm 49 tumoral 49 #degreesC 49 dicarboxylic acid 49 placebo dexamethasone 49 cm ^ sup 49 AUC0 #hr 49 esophageal tumors 49 postdose 49 caustic soda sodium hydroxide 49 CIMZIA TM 49 Figure 2C 49 mL min 49 aminotransferase ALT 49 serum urate levels 49 t# c# CLA 49 hypericin 49 hypoperfusion 49 paraprotein 49 mononuclear 49 cm -2 49 infused intravenously 49 supraclavicular 49 P ≤ 49 millidarcies 49 elevated LDH 49 deadweight dwt 49 definite stent thrombosis 49 steroid dexamethasone 49 decompressions 49 mutated K ras 49 preintervention 49 alanine aminotransferase 49 mGy 49 periventricular 49 chemoradiation therapy 49 CK MB 49 g dl 49 receiving ISENTRESS 49 #.#ng/ml 49 Median PFS 49 #mm# [003] 49 biopsy specimens 49 Qmax 49 intramuscular dose 49 microfilaria 49 milliampere 49 #x# ^ 49 epitaxial layer 49 pCR 49 μg dL 49 Fig. 2A 49 serum creatinine levels 49 pin SSOP package 49 mg/m2 dose 49 #.#x#.#mm 49 log# 49 inhibitory concentration 49 #mg/kg [001] 49 Fx adj 49 μm diameter 49 equimolar 49 UPDRS motor 49 GORE TAG Device 48 #ng/ml 48 X ray diffraction pattern 48 mm Hg systolic 48 Alanine 48 CLA isomers 48 HGPIN 48 tolterodine ER 48 mg RDEA# 48 PREZISTA ritonavir 48 Ishak fibrosis score 48 aminotransferases 48 lesional 48 serum urate 48 #ug [002] 48 sq cm 48 Apidra ® 48 GFlops 48 prilocaine 48 #mm ² [002] 48 AUC0 48 CrCl 48 millimeter diameter 48 CSDs Dr Pepper 48 LEXIVA r 48 BBs lodged 48 lipoprotein particle 48 nucleotide substitutions 48 metastatic carcinoid tumors 48 cubic milliliter 48 creatine phosphokinase 48 locoregional recurrence 48 inotropic 48 baseline FEV 48 pDNA 48 quotation KZT 48 urinary protein 48 #.#/#.# mmHg [001] 48 receiving prophylactic anticoagulation 48 pCi l 48 hMG 48 fig. S6 48 indinavir 48 ^ sup -1 48 necrotic tissue 48 Index CDAI 48 undetectable HBV DNA 48 TUNEL 48 CDAI 48 electrolyte membrane 48 isoprostane 48 hetastarch 48 tipranavir r 48 bolus dose 48 budesonide pMDI 48 PRADAXA #mg 48 mCi kg 48 #mm ² [001] 48 anthracycline chemotherapy 48 antibody titer 48 serum CRP 48 ulcerative proctitis 48 inhaled fluticasone 48 #mm Hg 48 hematologic toxicity 48 coronary stenosis 48 intradermally 48 μg liter 48 foveal thickness 48 tph 48 IQR 48 mL vials 48 t/m3 48 hemoglobin Hb 48 QRS duration 48 generalized edema 48 intramuscularly 48 m z 48 mg m² 48 interleukin IL -6 48 alveolar bone loss 48 Doppler sonography 48 g/m3 48 μmol 48 cefotaxime 48 cm ² 48 #.degree [001] 48 estimated glomerular filtration 48 postoperative complication 48 ALT flares 48 REYATAZ r arm 48 PLX STROKE targeting 48 T2 weighted images 48 azacytidine 48 pretreatment baseline 48 supernatants 48 rectal tenesmus 48 systemic hypotension 48 Fig. 1c 48 histrelin 48 atorvastatin #mg 48 detrusor 48 fig. S2 48 BWPD 48 intestinalis 48 analyte 48 urate lowering therapy 48 milliohm 48 biochemical relapse 48 KBytes 48 micrometer scale 48 μmol l 48 nmol L. 48 megabits sec 48 tbsp honey 48 crystalloid 48 dehiscence 48 lumbar spine BMD 48 TPV r 48 % miconazole nitrate 48 extracapsular extension 48 PBGA package 48 lispro 48 oxyhemoglobin 48 -#.# log# 48 hydroxyphenyl 48 % CI #.#-#.# [008] 48 statistically significant p = 48 byte FIFO 48 metaplasia 48 Sodium hypochlorite 48 λ 48 serum phosphorous 48 deoxy 48 log# copies mL 48 intratumoral 48 anemia hemoglobin 48 #mg doses [002] 48 proteinaceous 48 statin monotherapy 48 Terawatt hours 48 breast carcinomas 48 stage IIIb IV 48 kg m² 48 solutes 48 intestine colon 48 g carbo 48 Intraocular pressure 48 osmolality 48 pooled comparator 48 deferoxamine 48 β galactosidase 48 lanthanum carbonate 48 HepG2 cells 48 FEV1 forced expiratory 48 urinary excretion 48 dorsum 48 mean baseline A1C 48 pN 48 sq. cm 48 expiratory flow 48 SETDB1 48 CFU g 48 milliamp 48 mIU L 48 tumor biopsies 48 intravenous heparin 48 ARB telmisartan 47 BMS p = 47 cfu 47 GFLOPs 47 MACCE 47 plus aztreonam 47 #OHD 47 milligrams deciliter 47 ug L 47 arteriolar 47 scrapie infected 47 microampere 47 5-FU/LV 47 cells mcL 47 dalteparin 47 mg BID dose 47 baseline A1C 47 flutamide 47 cfu g 47 μV 47 chondroitin sulphate 47 mg kg 47 transmissivity 47 yttrium oxide 47 imiquimod cream 47 recurrent venous thromboembolism 47 symptomatic intracranial hemorrhage 47 troponin T 47 glulisine 47 nanometers nm 47 kg hr 47 SOCS3 47 proBNP 47 HbA 1c levels 47 terabecquerel 47 #mg/m# [002] 47 polymyxin B 47 ß amyloid 47 gastric mucosa 47 ethambutol 47 3mg/kg 47 Tumor shrinkage 47 methemoglobin 47 heterozygotes 47 creatine phosphate 47 #mg BID [001] 47 kbits 47 ZrO 2 47 HDL particle 47 graft occlusion 47 dissolved salts 47 #x#mm package 47 HI titers 47 IIIa inhibitors 47 tortuosity 47 piperacillin tazobactam 47 intra articular injection 47 cm -3 47 IV bolus 47 mg eq 47 bolus injection 47 P = .# 47 mg Androxal 47 transmural 47 #.#-#.# [011] 47 rms noise 47 amoxicillin clavulanate 47 oxycodone IR 47 m3/hr 47 undetectable viral 47 Hb A1C 47 dextrose monohydrate 47 lipoprotein cholesterol 47 Leucovorin 47 rt PA 47 NovoLog ® Mix 47 EDSS scores 47 kPa 47 salmeterol fluticasone 47 mg simvastatin 47 RNA fragments 47 dimethyl sulfoxide 47 quadrillionths 47 hemolymph 47 isotonic saline 47 fibrinolysis 47 mg ml 47 #.#mm# [001] 47 microns millionths 47 nitroprusside 47 mcg kg 47 5FU 47 mm Hg diastolic 47 computed tomographic scan 47 mg kg ip 47 metformin monotherapy 47 Febrile neutropenia 47 fluorescence intensity 47 enhanced sonography 47 Replikin Count 47 nonsignificant difference 47 HBeAg seroconversion 47 p = .# [002] 47 multi walled nanotubes 47 CCyR 47 elutes 47 micron diameter 47 log# IU mL 47 trochanter 47 millimoles per 47 abdominal circumference 47 bladder tumors 47 CFUs 47 #mg/dL [002] 47 Fig. 1B 47 thrombocytopenic patients 47 leucopenia 47 unformulated vaccine 47 hemoglobin A1c levels 47 progression TTP 47 mg/m2/day 47 serum bilirubin 47 BRAF protein 47 striated muscle 47 microtubes 47 globulin 47 apolipoprotein B 47 partial remissions 47 conjunctival hyperemia 47 lymphocytosis 47 pegaptanib 47 Severe hypoglycemia 47 mL 47 ventricular myocardium 47 postinjury 47 CI #.#-#.# [001] 47 Mbps throughput 47 subconjunctival 47 antiseptic chlorhexidine 47 #.#cc [001] 47 epoetin alpha 47 adjunctive placebo 47 #mg/day [002] 47 Fasting plasma glucose 47 6nm 47 m ^ sup 47 micrometres 47 transaminase 47 units cfu 47 megabits Mb 47 nicardipine 47 Crohn Disease Activity 47 mRNA encoding 47 crossclamp 47 ERK activation 47 ACR Pedi 47 nanosponge particles 47 RMS jitter 47 nitrite nitrate 47 milliliters ml 47 ppm boron 47 micrometre scale 47 g t Ta 47 busulfan 47 euthyroid 47 p# biomarker 47 serum HBV DNA 47 Vitamin B2 47 bone allografts 47 insulin glulisine 47 xenograft tumors 47 placebo PBO 47 mA output 47 nanogram 47 fructosamine 47 Å -1 47 ng dL 47 MTT assay 47 scf ton 47 Supplementary Table 47 serum TSH 47 pulmonary arterial 47 serum lipid levels 47 Rectal cancer 47 urinary albumin 47 milligauss 47 incontinence episodes 47 cobalamin 47 ferrous sulfate 47 induration 47 recurrent VTE 47 mEq L. 47 QRS width 47 rizatriptan 47 Nm3 h 47 rotifer 47 alexandrite laser 47 cm incision 47 BUPHENYL R sodium phenylbutyrate 47 milliwatt 47 nm excitation 47 trillion ppt 47 reintubation 47 #x# multipliers 47 ^ F FDG 47 neointimal 47 ganciclovir 47 euvolemic 47 lacrimal gland 47 tylosin 47 roentgen 47 kB 47 2dB 47 intravenous IV infusion 47 Ncm 47 Desferal 47 respirable 47 intraocular pressure IOP 47 mean baseline HbA1c 47 dehydrogenase 47 ° С 47 vastus lateralis 47 Mg Uk 47 streptokinase 47 mrem 47 PD# [005] 47 mT 47 mW cm 2 47 permanently discontinue Vectibix 47 achieving PASI 47 baseline Hb 47 mouse embryonic 47 CIN2 + 47 inhibited tumor 47 lateral radiographs 47 HIV RNA 47 glioblastoma tumors 47 multinucleated 47 unencapsulated 47 hepatoma 46 flow mediated dilation 46 #.#mln ton [003] 46 bronchoalveolar lavage BAL 46 iodinated contrast 46 SGRQ 46 #mg BID [003] 46 SiO 2 46 hydroxyproline 46 detectable HCV RNA 46 #mm x #.#mm [001] 46 serum potassium 46 Tmax 46 mercury Hg 46 femora 46 griseofulvin 46 mg Proellex 46 MCyR 46 peak VO2 46 hilar 46 #.#mg/kg [001] 46 Gb NAND 46 Mg ha 46 Operative mortality 46 macrolide antibiotic 46 dose dabigatran 46 moderately emetogenic 46 CR nPR 46 MADRS score 46 T#/E# circuits 46 vasogenic edema 46 technology produces picoliter 46 SITEL manages 46 fluorodeoxyglucose 46 postintervention 46 #cm 3ft 46 ovariectomized 46 postoperative morbidity 46 chromosomal mutations 46 Secretase 46 mg hydrochlorothiazide 46 nephrotoxic 46 calcific 46 micro sievert 46 absorbance 46 protein excretion 46 intravenously administered 46 #mg/m# [001] 46 CIN3 46 plasma concentrations 46 CaO 46 carmustine 46 sarcomere 46 myocardial reperfusion 46 remifentanil 46 voxels 46 sonication 46 bovine thrombin 46 nmol L 46 gene deletions 46 Soriatane R 46 procollagen 46 daunorubicin 46 controlled analgesia PCA 46 miconazole nitrate 46 Stent p = 46 systemic corticosteroids 46 kilogram mg kg 46 cm -1 46 km3 46 cm sec 46 mg/# hours 46 GNRs 46 placebo capsules 46 #u [001] 46 Cmax 46 subcutaneously 46 capacitances 46 mg kg -1 46 methylprednisolone steroid 46 transaminases 46 distal clavicle 46 SCFM 46 beamformer 46 Mg Usa 46 glyceryl trinitrate 46 CD3 + 46 #.#mg dose 46 trihydrate 46 cancellous 46 silica nanoparticles 46 ureteral 46 x 7mm 46 perfused 46 dielectric permittivity 46 #mg #mg #mg [003] 46 #mcm 46 Postoperative complications 46 g l 46 mg ustekinumab 46 HCV replicon 46 riboflavin vitamin B2 46 certolizumab 46 glomerular filtration rate 46 myocardial tissue 46 hepatic resection 46 blastomeres 46 CD4 + cells 46 fatigue asthenia 46 REMICADE monotherapy 46 dopamine partial agonist 46 mg p = 46 dB SPL 46 plus GP IIb 46 antiandrogen 46 sestamibi 46 serum prostate 46 Quiescent current 46 ^ sup 46 % CI #.#-#.# [001] 46 oral prednisone 46 subcutaneous abdominal 46 Fig. 2b 46 mU L